Clinical Trials Browser

Risk Reduction Behavior × 1 year × Clear all

NCT00040222 2026-03-09

Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer

Breast Cancer, Familial, Breast Neoplasms, Hamartoma Syndrome, Multiple, Ovarian Neoplasms, Peutz-Jeghers Syndrome, Li-Fraumeni Syndrome, Risk Reduction Behavior

NCT04821141 2025-10-29

Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

Phase 2 Active not recruiting

120 enrolled

Breast

Breast Neoplasms, Hot Flashes, Risk Reduction Behavior

NCT03985852 2025-09-22

BRIDGE

Phase NA Completed

3,073 enrolled 7 charts

Neoplasms, Risk Reduction Behavior

NCT06968884 2025-05-13

Application of a Comprehensive Protocol Aimed at Reducing the Risk of Complications After Surgery for Sarcoma. Interventions Before, During and After Surgery for Known and Presumed Risk Factors Compared to Standard of Care in a Total of 300 Patients.

Phase NA Enrolling by invitation

300 enrolled

Sarcoma

Sarcoma, Risk Reduction Behavior